中国P站

Point-of-care testing (POCT) refers to diagnostic testing performed at or near the site of patient care, providing rapid results that can inform immediate clinical decisions. Unlike traditional laboratory testing, which requires specimen transport, centralized processing, and delayed reporting, POCT delivers timely information, often within minutes. This approach has transformed healthcare delivery, improving patient outcomes, reducing hospital stays, and enhancing disease management across diverse settings, from primary care clinics to emergency departments and remote locations. The growing availability of portable and user-friendly diagnostic devices has further expanded the reach and utility of POCT, making it a cornerstone of modern healthcare [1,2].

Discussion

POCT encompasses a wide range of diagnostic tests, including blood glucose monitoring, rapid antigen and antibody tests for infectious diseases, cardiac biomarkers, coagulation testing, and molecular assays. These tests are particularly valuable in acute care scenarios, such as emergency rooms, intensive care units, or during outbreaks, where rapid decision-making is critical. For instance, rapid diagnostic tests for influenza or SARS-CoV-2 enable immediate isolation and treatment, minimizing transmission and improving patient management. Similarly, bedside measurement of cardiac troponins can expedite diagnosis and treatment of myocardial infarction, directly impacting survival rates [3-6].

The advantages of POCT extend beyond speed. By providing immediate results, these tests reduce the need for multiple patient visits, streamline clinical workflows, and enhance patient engagement. In resource-limited or remote settings, POCT bridges gaps where access to centralized laboratories is limited, supporting equitable healthcare delivery. Additionally, integrating POCT into clinical decision-making can reduce unnecessary treatments, improve antibiotic stewardship, and enhance overall healthcare efficiency [7,8].

Technological advancements have significantly expanded the capabilities of POCT. Modern devices include handheld analyzers, microfluidic chips, and biosensors capable of performing complex assays with high accuracy and minimal sample volume. Many systems incorporate connectivity features, allowing results to be automatically recorded in electronic health records and enabling real-time monitoring for public health surveillance. Recent innovations, such as point-of-care molecular testing and multiplex platforms, allow rapid detection of multiple pathogens or biomarkers simultaneously, further enhancing clinical utility [9,10].

Despite its advantages, POCT presents challenges that must be addressed. Accuracy and reliability can be affected by operator error, environmental conditions, or device calibration. Therefore, proper training, quality control measures, and adherence to regulatory standards are essential.

Conclusion

Point-of-care testing has revolutionized healthcare by enabling rapid, near-patient diagnostics that improve clinical decision-making, patient outcomes, and operational efficiency. From routine monitoring to acute care and infectious disease management, POCT empowers clinicians to act swiftly and effectively. Technological advancements continue to expand its scope, while integration with electronic health systems and quality assurance protocols ensures reliability and accuracy. As healthcare increasingly emphasizes timeliness, accessibility, and patient-centered care, POCT stands as a critical tool, bridging laboratory science and bedside practice, and shaping the future of diagnostic medicine globally.

References

1. Klastersky J, Aoun M (2004) . Ann Oncol 15: 329–335.

   , ,

2. Klastersky J (1998) . Rev Mal Respir 15: 451–459.

   ,

3. Duque JL, Ramos G, Castrodeza J (1997) . Ann Thorac Surg 63: 944–9950.

   , ,

4. Kearny DJ, Lee TH, Reilly JJ (1994) . Chest 105: 753–758.

   , ,

5. Busch E, Verazin G, Antkowiak JG (1994) . Chest 105: 760–766.

   , ,

6. Deslauriers J, Ginsberg RJ, Piantadosi S (1994) . Chest 106: 329–334.

   , ,

7. Belda J, Cavalcanti M, Ferrer M (2000) . Chest 128:1571–1579.

   , ,

8. Perlin E, Bang KM, Shah A (1990) . Cancer 66: 593–596.

   , ,

9. Ginsberg RJ, Hill LD, Eagan RT (1983) . J Thorac Cardiovasc Surg 86: 654–658.

   , ,

10. Schussler O, Alifano M, Dermine H (2006) . Am J Respir Crit Care Med 173: 1161–1169.

    , ,